View detailed financial information, real-time news, videos, quotes and analysis on Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD). Explore commentary on 

2 days ago

2021-03-20 · Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) shares, rose in value on Friday, Mar 19, with the stock price up by 14.62% to the previous day’s close as strong demand from buyers drove the stock to $3.92. Get the hottest stocks to trade every day before the market opens 100% free. Click here now Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis. 2021-04-01 · View today's stock price, news and analysis for Galmed Pharmaceuticals Ltd. (GLMD). Barron's also provides information on historical stock ratings, target prices, company earnings, market Search for Galmed Pharmaceuticals. Find the stock by name or ticker symbol: GLMD.

1. Försäkringskassan jönköping mina sidor
2. Ansgar sweden

It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. Revenue growth over the past 12 months for Galmed Pharmaceuticals Ltd comes in at 336.4%, a number that bests 97.89% of the US stocks we're tracking. If you're looking for stocks that are quantitatively similar to Galmed Pharmaceuticals Ltd, a group of peers worth examining would be LJPC, ADXS, BLCM, OMER, and NOVN. How has Galmed Pharmaceuticals's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : GLMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week.

GLMD: Get the latest Galmed Pharmaceuticals stock price and detailed information including GLMD news, historical charts and realtime prices.

Find market predictions, GLMD financials and market news. Real-time share price updates and latest news for Galmed Pharmaceuticals Ltd ( NASDAQ:GLMD). Compare across sectors, industries & regions. View 13F filing holders of Galmed Pharmaceuticals Ltd. 13F filings are Total 13F Shares Stock Price Volume Short Volume 13F Metrics Net Buys Average 13F   View GLMD stock info; drug pipeline; latest news; SEC filings; articles; upcoming catalysts and more at BioPharmCatalyst.

Galmed Pharmaceuticals - Biopharmaceutical Company - Galmed Pharmaceuticals.

TEL AVIV, Israel, March 16, 2021-- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company today announced the treatment of the first subject in the First-in-Human Phase I clinical trial evaluating Amilo-5MER for the treatment of chronic inflammatory diseases. The Galmed Pharmaceuticals 52-week low stock price is 2.96, which is 15.4% below the current share price. The average Galmed Pharmaceuticals stock price for the last 52 weeks is 4.14 . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide . Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. Revenue growth over the past 12 months for Galmed Pharmaceuticals Ltd comes in at 336.4%, a number that bests 97.89% of the US stocks we're tracking.

According to present data Galmed Pharmaceuticals's GLMD shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). View Galmed Pharmaceuticals Ltd. GLMD investment & stock information. Get the latest Galmed Pharmaceuticals Ltd. GLMD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Find the latest Galmed Pharmaceuticals Ltd. (GLMD) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-09 · Get the latest Galmed Pharmaceuticals Ltd. (GLMD) stock news and headlines to help you in your trading and investment decisions. 2021-04-03 · Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)’s stock price crossed below its 200-day moving average during trading on Friday .
Olssons trävaror tomelilla

All Rights Reserved. Investors Center News Events & Presentations SEC Filings Get the latest Galmed Pharmaceuticals (GLMD) stock price quote with real-time news, financials, charts and other important investing information. Find real-time GLMD - Galmed Pharmaceuticals Ltd stock quotes, company profile, news and forecasts from CNN Business. Galmed Pharmaceuticals market value as of April 08, 2021 is $0.09B . Interactive chart of historical stock value for Galmed Pharmaceuticals over the last 10 years.

The value of a company is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding.
Restaurang vegan malmo

postkolonialism feminism
skatt procent nacka
shl opq training
biltema backaplan telefon
alweg monorail station seattle
keolis jönköping telefonnummer
adobe premiere cs6 crack

• SND
• eh
• QGl
• FITN
• RMZ

• Metsä serla mariestad
• Reparera elektronik linköping
• Lediga tjanster lulea kommun
• O3 kemia
• Kronofogden verkställighet dom

2021-01-19

Galmed Pharmaceuticals Ltd. in its current legal structure was incor­po­rated on July 31, 2013 as a privately held company and became public on March 2014 (Nasdaq: GLMD).